Firstly is was a different psych (MDMA) on a different...

Firstly is was a different psych (MDMA) on a different condition. Secondly the issue was not the results but the way it was run and changing conditions to meet a favourable outcome. Very, very different.

We have great results thus far and like always the good trials and drugs will always succeed if the outcome and safety is beneficial. That landscape is changing every day. By the time our Phase 3 is done it will look very different I would suggest.

It does also highlight how important it is to have so many programs in our war chest.